Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
Status:
Completed
Trial end date:
2018-11-26
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if ipilimumab is effective in preventing or delaying
recurrence and prolongs survival after complete resection of high risk stage III melanoma